GlassScriptPhysician profile
Darshan B Patel
NPI 1366670457
$2,795.88
in general payments reported to CMS, 2019-2025
15 companies · $2,332 in 2025
The $2,332 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $166 · 2023: $24.66 · 2024: $273 · 2025: $2,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,516 · Travel and Lodging: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.34 |
| Travel and Lodging | $1,113.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,507.08 | 2022-2025 | Proclaim, Durata, Eterna |
| Boston Scientific Corporation | $626.25 | 2025 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $138.96 | 2024-2025 | Sprint Pns System |
| Averitas Pharma INC. | $136.70 | 2024 | Qutenza |
| Mml US, INC. | $90.46 | 2025 | Reactiv8 |
| Radius Health, INC. | $78.81 | 2025 | Tymlos |
| Janssen Biotech, INC. | $49.63 | 2025 | Tremfya |
| Octapharma USA, INC. | $26.74 | 2025 | Octagam Immune Globulin (Human) |
| Pfizer INC. | $25.99 | 2025 | |
| Ani Pharmaceuticals, INC. | $24.32 | 2025 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $22.97 | 2025 | |
| Genentech USA, INC. | $22.08 | 2025 | Gazyva |
| Tonix Medicines, INC. | $15.81 | 2025 | Tonmya |
| Astrazeneca Pharmaceuticals LP | $15.26 | 2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.